Circulation. 2006;114:1545-1548
doi: 10.1161/CIRCULATIONAHA.105.586487
(Circulation. 2006;114:1545-1548.)
© 2006 American Heart Association, Inc.
Statistical Primer for Cardiovascular Research |
Hypothesis Testing
Proportions
Kimberlee Gauvreau, ScD
From the Department of Cardiology, Childrens Hospital, Boston, Mass.
Correspondence to Kimberlee Gauvreau, ScD, Department of Cardiology, Childrens Hospital, 300 Longwood Ave, Boston, MA 02115. E-mail gauvreau@tch.harvard.edu
Key Words: statistics hypothesis testing
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
The process of drawing conclusions about an entire population
on the basis of the information contained in a random sample
drawn from that population is known as statistical inference.
Methods of statistical inference fall into 2 general categories:
estimation and hypothesis testing. With estimation, our goal
is to describe or estimate some characteristic of a population
of interest, such as the mean pulmonary regurgitation fraction
of all patients alive 10 years after repair of tetralogy of
Fallot or the proportion of children with acute Kawasaki disease
who develop coronary artery abnormalities. With hypothesis testing,
we begin by claiming that the population parameter of interest
is equal to some postulated value (or, in the situation in which
we are comparing 2 populations, that the 2 parameters are equal
to each other). This statement about the value of the population
parameter is called the null hypothesis (H
0). The alternative
hypothesis (H
A) is a second statement that contradicts the null.
Together, the null and alternative hypotheses account for all
possible values of the population parameter; consequently, 1
of the 2 statements must be true. After formulating the hypotheses
needed to answer our study question, we draw a random sample
from the population of interest and use the information in this
sample to calculate a test statistic. The test statistic is
compared with the critical values of an appropriate probability
distribution. If there is evidence that the sample could not
have come from a population with the postulated value of the
parameter,
. . . [Full Text of this Article]
This article has been cited by other articles:

|
 |

|
 |
 
B. E. G. Rothberg, M. B. Bracken, and D. L. Rimm
Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
J Natl Cancer Inst,
April 1, 2009;
101(7):
452 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.D. Hosgood III, I. Menashe, M. Shen, M. Yeager, J. Yuenger, P. Rajaraman, X. He, N. Chatterjee, N. E. Caporaso, Y. Zhu, et al.
Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway
Carcinogenesis,
October 1, 2008;
29(10):
1938 - 1943.
[Abstract]
[Full Text]
[PDF]
|
 |
|